SecBot SecBot
6-K ·Filed Apr 30, 2026

FMX

MEXICAN ECONOMIC DEVELOPMENT INC
MIXED
Impact 6/10
Horizonweeks Processed6mo ago SEC0001104659-26-052276
Notable filing: 6-K
Actionable Insight ◆ Mixed

The core retail business (OXXO Mexico) is performing well with accelerating margins, but Coca-Cola FEMSA's operating income decline and the 36.4% drop in adjusted net income are concerning. The non-renewal of the Colombia medication dispensing agreement adds uncertainty to the Health segment. Monitor the Q2 2026 conference call for guidance on Coca-Cola FEMSA margin recovery and the impact of the Cruz Verde contract termination. The elevated leverage (1.24x ND/EBITDA) from aggressive capital returns warrants watching.

DirectionMixed
Confidencehigh
Horizonweeks

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$118.24
T+0 close · Apr 30, 2026 · via day close
Latest settled
+11.76%
T+60 · $132.15
Vs SPY
+8.66%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 30 $118.24entry
  2. T+1 · 7mo ago +1.46%α +1.24% · $119.97
  3. T+5 · 6mo ago +3.32%α +1.60% · $122.17
  4. T+20 · 6mo ago +2.22%α −2.75% · $120.86
  5. T+60 · 4mo ago +11.76%α +8.66% · $132.15
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

FEMSA reported Q1 2026 results with consolidated revenue up 6.1% YoY to Ps. 207,784 million and operating income up 5.5% to Ps. 14,314 million, driven by strong performance at OXXO Mexico (revenue +8.3%, operating income +20.9%) and Americas & Mobility (+12.9% revenue). However, Coca-Cola FEMSA's operating income declined 2.3%, and Health operating income fell 14.2%. Net consolidated income surged 97.3% to Ps. 17,639 million, but excluding a one-time gain from the BradyPLUS/Imperial Dade merger, net income declined 36.4% to Ps. 5,688 million due to higher financing costs and FX losses. The company also announced a non-renewal of a medication dispensing agreement in Colombia and declared ordinary and extraordinary dividends.

Key Facts

  • FEMSA consolidated revenue grew 6.1% YoY to Ps. 207,784 million in Q1 2026; on a comparable basis, revenue grew 8.5%.
  • Consolidated income from operations increased 5.5% to Ps. 14,314 million; on a comparable basis, operating income grew 12.1%.
  • OXXO Mexico revenue grew 8.3% to Ps. 74,424 million, with operating income up 20.9% to Ps. 5,629 million.
  • Coca-Cola FEMSA revenue grew 1.1% to Ps. 70,925 million, but operating income declined 2.3% to Ps. 9,032 million.
  • Health division revenue grew 0.9% to Ps. 22,175 million, but operating income declined 14.2% to Ps. 657 million.
  • Consolidated net income was Ps. 17,639 million, up 97.3% YoY, but excluding a one-time gain from the BradyPLUS/Imperial Dade merger, net income was Ps. 5,688 million, a decline of 36.4%.
  • Net Debt/EBITDA ex-KOF increased to 1.24x from 0.69x in 1Q25, reflecting cash outflows for dividends (Ps. 47,218 million) and share repurchases (Ps. 16,055 million) over the last twelve months.
  • Cruz Verde Colombia notified EPS Sanitas of its decision not to renew the medication dispensing agreement under the Mandatory Health Plan, set to expire on September 30, 2026.
  • Shareholders approved ordinary dividend of Ps. 4.7520 per BD Unit and extraordinary dividend of Ps. 8.0597 per BD Unit, payable in four installments.

Financial Impact

Consolidated revenue grew 6.1% to Ps. 207,784 million; operating income up 5.5% to Ps. 14,314 million; net income up 97.3% to Ps. 17,639 million (but down 36.4% excluding one-time gain). Coca-Cola FEMSA operating income down 2.3%.

revenueoperating incomenet incomenet debt/EBITDA

Risk Factors

  • Coca-Cola FEMSA operating income declined 2.3% YoY, with Mexico & Central America operating income down 17.4% due to excise tax increases and restructuring costs.
  • Adjusted net income (ex-one-time gain) fell 36.4% due to higher financing costs, FX losses, and absence of discontinued operations income.
  • Net debt/EBITDA ex-KOF rose to 1.24x from 0.69x a year ago, driven by large dividend and buyback payouts.
  • Health division operating income declined 14.2%, and the non-renewal of the Cruz Verde Colombia medication dispensing agreement creates revenue risk for that segment.
  • Europe same-store sales declined 2.7% YoY, indicating soft consumer trends in Germany.

Market Snapshot

Exchange
NYSE
Sector
Bottled & Canned Soft Drinks & Carbonated Waters
Analyst Consensus
85% bullish (20 analysts)

Investment Themes

Consumer & Retail

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001104659-26-052276
Document: tm2613197d1_6k.htm0001104659-26-052276
Document: 0001104659-26-052276-index-headers.html0001104659-26-052276
Document: 0001104659-26-052276-index.html0001104659-26-052276
Document: 0001104659-26-052276.txt0001104659-26-052276

Track record

17 reports on FMX

Performance horizon

2 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +6.32% at T+20 after the Jun 8, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 10, 20266d ago Insider Cluster Neutral 2/10 Entry $132.53 to $130.72 Now $131.30 −0.93% ▼ −1.37% −1.01% vs SPY
  2. Oct 28, 202619d ago Press Release Bearish 5/10 Entry $123.70 to $124.28 Now $131.30 −6.14% ▼ −0.47% −0.85% vs SPY
  3. Oct 28, 202619d ago 6-K Neutral 5/10 Entry $123.70 to $124.28 Now $131.30 +6.14% ▲ +0.47% +0.85% vs SPY
  4. Oct 20, 202627d ago Institutional Cluster Bullish 4/10 Entry $127.98 to $129.03 Now $131.30 +2.59% ▲ +0.82% +2.00% vs SPY
  5. Oct 1, 20266w ago Press Release Neutral 1/10 Entry $115.68 Now $131.30 +13.50% No price data
  6. Sep 23, 20267w ago 6-K Neutral 3/10 Entry $117.71 to $119.62 Now $131.30 +11.55% ▲ +1.62% +1.08% vs SPY
  7. Sep 14, 20269w ago Press Release Neutral 4/10 Entry $121.26 to $121.60 Now $131.30 +8.28% ▲ +0.28% +0.74% vs SPY
  8. Sep 14, 20269w ago 6-K Bullish 4/10 Entry $121.26 to $121.60 Now $131.30 +8.28% ▲ +0.28% +0.74% vs SPY
  9. Jun 29, 202620w ago Press Release Neutral 1/10 Entry $127.90 to $128.11 Now $131.30 +2.66% ▲ +0.16% +0.30% vs SPY
  10. Jun 8, 202623w ago 6-K Bullish 5/10 Entry $122.51 to $122.20 Now $131.30 +7.17% ▼ −0.25% +0.04% vs SPY
Showing 10 of 17

US Market Status

Market Closed · Opens Wed (11h 3m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 30, 2026